rs150230450
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PP3BS1_SupportingPM3_Supporting
This summary comes from the ClinGen Evidence Repository: The c.6233C>G (p.Pro2078Arg) variant in USH2A was present in 0.39% (lower bound of the 95% CI of 50/10070) of Ashkenazi Jewish alleles in gnomAD v3. Although this population frequency is high enough to meet BS1, this evidence was downgraded to BS1_Supporting because this variant is likely a founder mutation in the Ashkenazi Jewish population. The p.Pro2078Arg variant was observed in one proband with retinitis pigmentosa and a second pathogenic variant in USH2A (PM3_Supporting; Hadassah-Hebrew University Medical Center internal data, ClinVar SCV001161352.1). It has also been seen in at least 4 probands without a second variant identified in USH2A (Laboratory for Molecular Medicine and Invitae internal data, ClinVar SCV000201902.5, SCV001068267.2). The REVEL computational prediction tool produced a score of 0.702, which is above the threshold necessary to apply PP3. In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1_Supporting, PM3_Supporting, PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA179550/MONDO:0019501/005
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.6233C>G | p.Pro2078Arg | missense_variant | 32/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.6233C>G | p.Pro2078Arg | missense_variant | 32/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000674083.1 | c.6233C>G | p.Pro2078Arg | missense_variant | 32/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152026Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000235 AC: 59AN: 251166Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135710
GnomAD4 exome AF: 0.000118 AC: 173AN: 1461624Hom.: 2 Cov.: 34 AF XY: 0.000109 AC XY: 79AN XY: 727124
GnomAD4 genome AF: 0.000145 AC: 22AN: 152026Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74248
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2024 | Reported in association with retinitis pigmentosa in published literature (PMID: 31456290); however, limited clinical and segregation information provided; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31456290) - |
Retinitis pigmentosa Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 17, 2013 | The Pro2078Arg variant in USH2A has not been reported in individuals with hearin g loss, but has been identified in 0.02% (1/4406) of African American chromosome s by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSN P rs150230450). Computational analyses (biochemical amino acid properties, conse rvation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Pro2078Arg variant may impact the protein, though this information is not predictive enough to determi ne pathogenicity. In summary, additional data is needed to determine the clinica l significance of this variant. - |
Usher syndrome Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Hearing Loss Variant Curation Expert Panel | Jun 24, 2020 | The c.6233C>G (p.Pro2078Arg) variant in USH2A was present in 0.39% (lower bound of the 95% CI of 50/10070) of Ashkenazi Jewish alleles in gnomAD v3. Although this population frequency is high enough to meet BS1, this evidence was downgraded to BS1_Supporting because this variant is likely a founder mutation in the Ashkenazi Jewish population. The p.Pro2078Arg variant was observed in one proband with retinitis pigmentosa and a second pathogenic variant in USH2A (PM3_Supporting; Hadassah-Hebrew University Medical Center internal data, ClinVar SCV001161352.1). It has also been seen in at least 4 probands without a second variant identified in USH2A (Laboratory for Molecular Medicine and Invitae internal data, ClinVar SCV000201902.5, SCV001068267.2). The REVEL computational prediction tool produced a score of 0.702, which is above the threshold necessary to apply PP3. In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1_Supporting, PM3_Supporting, PP3. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 27, 2016 | - - |
Usher syndrome type 2A Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 17, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at